FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation

Acta Pharmacologica Sinica

Volumn 24, Issue 9, 2003, Pages 847-852

  Wang, Ming Hui ^a,b   Vitaliy, Milekhin ^a   Zhang, Hua ^b   Huang, Hong Zheng ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

FTY720; Heart; Heterologous transplantation; Lymphocytes; Mice; Rescue therapy

Indexed keywords

FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; RESCUE THERAPY; TREATMENT OUTCOME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDIUM; PROPYLENE GLYCOLS; SPHINGOSINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0041317124     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: eleventh official report-1994. J Heart Lung Transplant 1994; 13: 561-70.
2. Conrad SA, Chhabra A, Vay D. Long-term follow up and complications after cardiac transplantation. J La State Med Soc 1993; 145: 217-220, 223-5.
3. Oaks TE, Wallwork J. Cardiac transplantation: a review. Br J Biomed Sci 1993; 50: 200-11.
4. Yeatman M, Smith JA, Dunning JJ, Large SR, Wallwork J. Cardiac transplantation: a review. Cardiovasc Surg 1995; 3: 1-14.
5. Nair RV, Morris RE. Immunosuppression in cardiac transplantation: a new era in immunopharmacology. Curr Opin Cardiol 1995; 10: 207-17.
6. Adachi K, Kohara T, Mishina T, Fujita T. Design, synthesis, and structure activity relationship of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem 1995; 5: 853-6.
7. Hong JC, Kahan BD. Immunosuppressive agents in organ transplantation: past, present, and future. Semin Nephrol 2000; 20: 108-25.
8. Napoli KL. The FTY720 story. Ther Drug Monit 2000; 22: 47-51.
9. Suzuki S, Enosawa S, Kakefuda T, Shinomiya T, Amari M, Naoe S, et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996; 61: 200-5.
10. Yanagawa Y, Hoshino Y, Chiba K. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival. Int J Immunopharmacol 2000; 22: 597-602.
11. Ohba M, Li XK, Kita Y, Enosawa S, Funeshima N, Nagai H, et al. Long-term graft acceptance in rat heart transplantation by gene transfection combined with fty720 treatment. World J Surg 2001; 25: 391-7.
12. Furukawa H, Suzuki T, Jin MB, Yamashita K, Taniguchi M, Magata S, et al. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720. Transplantation 2000; 69: 235-41.
13. Ueda H, Takahara S, Azuma H, Kusaka M, Suzuki S, Katsuoka Y. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats. Eur Surg Res 2000; 32: 279-83.
14. Koshiba T, Ji P, Tanaka K, McMaster P, Van Damme B, Waer M, Pirenne J, et al. Tolerance induction with FTY720 and donor-specific blood trasnsfusion: discrepancy between heart transplantation and intestinal transplantation. Transplant Proc 2000; 32: 1255-7.
15. Suzuki K, Kazui T, Kawabe A, Li XK, Funeshima N, Amemiya H, Suzuki S. Immunosuppressive effect of FTY720 on rat pancreas allograft. Transplant Proc 1998; 30: 3417.
16. Fu F, Hu S, Li S, DeLeo J, Hoover J, Wang S, Lake P, Shi V, et al. FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model. Transplant Proc 2001; 33: 672-3.
17. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343-50.
18. Yuzawa K, Otsuka M, Taniguchi H, Takada Y, Sakurayama N, Jinzenji Y, et al. Rescue effect of FTY720 on acute renal rejection in dogs. Transplant Proc 1999; 31: 872.
19. Hwang MW, Matsumori A, Furukawa Y, Ono K, Okaa M, Iwasaki A, et al. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Circulation 1999; 100: 1322-9.
20. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K, et al. FTY720, a novel immunosuppressant, induces sequestration circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998; 160: 5493-6.
21. Chiba K, Hoshino Y, Suzuki C, Masubuchi Y, Yanagawa Y, Ohtsuki M, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rat. Transplant Proc 1996; 28: 1056.
22. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allograft and synergistic effect in combination with cyclosporine A. Transplant Proc 1996; 28: 1060.
23. Enosawa S, Suzuki S, Kakefuda T, Li XK, Amemiya H. Induction of selective cell death targeting on mature T lymphocytes in rats by a novel immunosuppressant; FTY720. Immunopharmacology 1996; 34: 171-9.
24. Suzuki S, Li XK, Enosawa S, Shinomiya T. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 1996; 89: 518-23.
25. Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats: I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998; 160: 5037-44.
26. Pinschewer DD, Ochsenbein AF, Odermatt B, Brinkmann V, Hengartner H, Zinkernagel RM. FTY720 immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion, and memory. J Immunol 2000; 164: 5761-70.
27. Brinkmann V, Pinschewer D, Chiba K, Feng L. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol Sci 2000; 21: 49-52.